Hyperfine Inc Ordinary Shares - Class A HYPR 深 滬
等待開盤 07-17 09:30:00 美东时间
0.80
-0.005
-0.62%
華盛通- 最 高0.8111
- 今 開0.805
- 成交量 12.35万股
- 最 低 0.78
- 昨 收 0.805
- 總市值 6227.19万
- 52周最高 1.90
- 市盈率 靜 --
- 換手率 0.16%
- 52周最低 0.5327
- 委 比 78.79%
- 總股本 7783.99万
- 歷史最高 16.61
- 量 比 0.94
- 振 幅 3.86%
- 歷史最低 0.5327
- 每 手 1
- 風險率 0.19%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Harrison Global Teams Up With HYPRCOMMUNITY CO., To Deliver AI-Driven VTuber Social Platform
TOKYO, JP / ACCESS Newswire / July 14, 2025 / Harrison Global Holdings Inc. (NASDAQ:BLMZ) ("Harrison Global" or the "Company"), a Japanese audio production, VTuber, entertainment, and voice actor management company, has
07-15 04:08
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Ironwood Pharmaceuticals (NASDAQ:IRWD) stock rose 15.2% to $0.71 durin...
06-14 05:05
Nvidia Just Partnered With A Weight-Loss Giant, But It's Not About Pills
Nvidia teams up with Novo Nordisk and IQVIA to boost AI-powered drug development and streamline complex pharmaceutical workflows.
06-13 00:51
Hyperfine Stock Is Soaring Higher Monday: What's Going On?
Hyperfine announced it secured clearance from the FDA for its new Swoop system.
06-03 02:30
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Lyra Therapeutics (NASDAQ:LYRA) stock rose 376.8% to $23.5 during Mond...
06-03 01:06
Hyperfine Secures FDA Clearance For Next-Gen AI-Powered Portable MRI Scanner
This major Swoop® system scanner redesign and Optive AI™ software elevate the AI-powered portable MRI experience for clinicians and their patients across multiple sites of care.Hyperfine, Inc. (NASDAQ:HYPR),
06-02 20:18
Hyperfine Chairperson R. Scott Huennekens Resigns
Hyperfine ( ($HYPR) ) has issued an update. On May 21, 2025, R. Scott Huenneken...
05-24 05:48
美股大行评级 | 潜在涨幅2840.31%！Mersana Therapeutics获Truist Securities升目标价至10美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130419824951111681.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Truist Securities：维持Mersana Therapeutics(MRSN)"买入"评级，目标价从9美元升至10美元</p> <p>• Guggenheim：维持Cabaletta Bio(CABA)"买入
05-17 08:44
美股大行评级 | 潜在涨幅1281.22%！Cabaletta Bio获Guggenheim升目标价至25美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130057143861719040.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持Cabaletta Bio(CABA)"买入"评级，目标价从23美元升至25美元</p> <p>• 瑞穗：维持Tectonic Therapeutic(TECX)"跑赢大市"评级，目标价从51美元
05-16 08:43
